UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported) November 11, 2019
SUNLINK HEALTH SYSTEMS, INC.
(Exact Name Of Registrant As Specified In Charter)
|
|
|
|
|
|
|
Ohio |
|
1-12607 |
|
31-0621189 |
|
(State or other Jurisdiction of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
|||
|
900 Circle 75 Parkway, Suite 1120, Atlanta, Georgia |
|
30339 |
||
|
(Address of principal executive offices) |
|
(Zip Code) |
||
Registrant’s telephone number, including area code (770) 933-7000
(Former Name Or Former Address, If Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( see General Instruction A-2. below:
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a.-12) |
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities Registered Pursuant to Section 12(b) of the Act:
|
Title of each Class |
Trading Symbol |
Name of each Exchange on which registered |
|
Common Shares without par value Preferred Share Purchase Rights |
SSY - |
NYSE American, LLC - |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders
The following matters were submitted to a vote of common shareholders at the 2019 annual meeting of stockholders of SunLink Health Systems, Inc. (the “Company”) held on November 11, 2019:
Election of Directors
Management’s nominees for election to the board of directors, as listed in the Company’s proxy statement, were elected for two-year terms; with the results of the voting as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nominee |
|
For |
|
|
Withheld |
|
|
Against |
|
|
Broker |
|
||||
|
Robert M. Thornton, Jr. |
|
|
3,894,618 |
|
|
1, |
416,265 |
|
|
|
0 |
|
|
|
1,144,588 |
|
|
Dr. Steven J. Baileys |
|
|
4,024,135 |
|
|
|
1,286,748 |
|
|
|
0 |
|
|
|
1,144,588 |
|
|
Gene E. Burleson |
|
|
3,941,005 |
|
|
|
1,369,878 |
|
|
|
0 |
|
|
|
1,144,588 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As indicated in the table above, Robert M. Thornton, Jr., Dr, Steven J. Baileys and Gene E. Burleson were elected as directors for terms expiring at the 2021 annual meeting of shareholders. The terms of the following incumbent directors continue until the 2020 annual meeting of shareholders: C. Michael Ford, Christopher H. B. Mills and Howard E. Turner.
Management also proposed the ratification of the appointment of the Company’s independent auditors for the 2020 fiscal year. The table below summarizes the results of the voting on these proposals by the Company’s stockholders:
Ratification of the appointment of Cherry Bekaert LLP as the Company’s Independent Registered Public Accounting Firm.
|
For |
|
Against |
|
Abstentions |
|
|
|
|
|
|
|
|
|
|
|
6,358,426 |
|
79,180 |
|
17,865 |
|
|
As indicated in the above table, the proposal to ratify the appointment of the Company’s independent auditors for the 2020 fiscal year was approved.
Ratification of the extension of the Tax Benefits Preservation Rights Plan.
|
For |
|
Against |
|
Abstentions |
|
|
|
|
|
|
|
|
|
|
|
3,224,203 |
|
1,863,295 |
|
223,385 |
|
|
As indicated in the above table, the proposal to extend the Plan’s Final Expiration Date from September 29, 2019 to September 29, 2024 was approved.
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
SUNLINK HEALTH SYSTEMS, INC. |
||
|
|
|
|
|
|
|
|
|
By: |
|
/s/ Mark J. Stockslager |
|
Name: |
|
Mark J. Stockslager |
|
Title: |
|
Chief Financial Officer |
Dated: November 13, 2019
3